Ysios Capital targets $78.7 mln for Fund II

Leading south European venture capital firm Ysios Capital has begun seeking investment in Ysios BioFund II, a 100 million Euro fund that will support life sciences companies with disruptive products, platforms or technologies in the pharmaceutical and medtech and diagnostics segments.

http://ift.tt/1nDlkcU